XLE-USD perpetual contract specifications
XLE on Aperi is a perpetual derivative linked to XLE-USD. Its reviewed catalogue contract is XLE-USD on ostium, using USDC collateral. This is price exposure; the contract does not deliver shares or ownership of the underlying asset.
Reviewed contract identity
- Product
- XLE-USD (XLE)
- Asset class
- ETFs
- Reviewed venue
- ostium
- Native contract
- XLE-USD
- Native market ID
- ostium.59.USDC
- Collateral
- USDC
- Quote currency
- USD
- Pricing model
- Oracle reference
- Classification
- Perpetual derivative
- Routing revision
- aperi-static-v1-2026-10-07
What this contract represents
XLE-USD-linked perpetuals do not confer share or fund ownership, voting rights or guaranteed dividends. Corporate actions and reference adjustments follow the venue and deployer specification.
24/7 perpetual markets remain subject to market availability, venue halts, oracle limits and liquidity. Understand perpetuals and ownership.
Market data and availability
The terminal provides current public observations separately from this reviewed contract description. Prices, funding, leverage ceilings and quantity increments come from the native venue when available. Missing observations remain unavailable.
Oracle venues provide reference quotes and OHLC where supported. Missing native books, trade tapes and candle volumes remain unavailable. The catalogue may select another reviewed route under its liquidity policy; an existing position retains its original venue identity.
Funded trading on Aperi is currently disabled. Public data, account login and a connected wallet do not establish trading permission. Read our data methodology.
Collateral, costs and risk
The reviewed route uses USDC. Funds remain separate per venue; a combined portfolio does not provide shared collateral or automatic transfer authority. Aperi's proposed platform fee is 0.05% of notional, subject to builder qualification. Total costs also include venue fees, spread, slippage and funding.
Leverage can amplify losses and trigger liquidation. This is product documentation, not an investment recommendation. Risk disclosure · Collateral and fees · Funding and liquidation.